Low p53 level in immortal, non-tumorigenic oral keratinocytes harboring HPV-16 DNA

Levine, 1990, Tumor suppressor genes, BioEssays, 12, 60, 10.1002/bies.950120203 Jenkins, 1985, The cellular oncogene p53 can be activated by mutagenesis, Nature, 317, 816, 10.1038/317816a0 Eliyahu, 1884, Participation of p53 cellular tumor antigen in transformation of normal embryonic cells, Nature, 312, 646, 10.1038/312646a0 Eliyahu, 1985, Overproduction of p53 antigen makes established cell highly tumorigenic, Nature, 316, 158, 10.1038/316158a0 Hinds, 1989, Mutation is required to activate the p53 gene for cooperation with ras oncogene and transformation, J Virol, 63, 739, 10.1128/JVI.63.2.739-746.1989 Mercer, 1991, Growth suppression induced by wild-type p53 protein is accompanied by selective down-regulation of proliferating-cell nuclear antigen expression, 88, 1958 Chiba, 1990, (for the lung cancer study group). Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer, Oncogene, 5, 1603 Rodrigues, 1990, p53 mutations in colorectal cancer, 87, 7555 Hsu, 1991, Mutational hotspot in the p53 gene in human hepatocellular carcinomas, Nature, 350, 427, 10.1038/350427a0 Scheffner, 1991, The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines, 88, 5523 Sidransky, 1991, Identification of p53 gene mutations in bladder cancers and urine samples, Science, 252, 706, 10.1126/science.2024123 Meltzer, 1991, Reduction to homozygosity involving p53 in esophageal cancers demonstrated by the polymerase chain reaction, 88, 4976 Meanwell, 1988, The epidemiology of human papillomavirus infection in relation to cervical cancer, Cancer Survey, 7, 481 Schwarz, 1985, Structure and transcription of human papillomavirus sequences in cervical carcinoma cells, Nature, 314, 111, 10.1038/314111a0 Shah, 1990, Papillomavirus infections of the respiratory tract, the conjunctiva, and the oral cavity, 73 Kaur, 1988, Characterization of primary human keratinocytes transformed by human papillomavirus type 18, J Virol, 62, 1917, 10.1128/JVI.62.6.1917-1924.1988 Woodworth, 1989, Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma, J Virol, 63, 159, 10.1128/JVI.63.1.159-164.1989 Park, 1991, Immortalization of normal human oral keratinocytes with type 16 human papillomavirus, Carcinogenesis, 12, 1627, 10.1093/carcin/12.9.1627 Park, 1992, Role of viruses in oral carcinogenesis Werness, 1990, Association of human papillomavirus types 16 and 18 E6 proteins with p53, Science, 248, 76, 10.1126/science.2157286 Scheffner, 1990, The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53, Cell, 63, 1129, 10.1016/0092-8674(90)90409-8 Romano, 1989, Identification and characterization of p53 gene mutation in a human osteosarcoma cell line, Oncogene, 4, 1483 Bartek, 1990, Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro, Int J Cancer, 46, 839, 10.1002/ijc.2910460515 Sakai, 1990, Immunohisto-chemical localization of c-myc oncogene product and EGF receptor in oral squamous cell carcinoma, J Oral Pathol Med, 19, 1, 10.1111/j.1600-0714.1990.tb00773.x Berenson, 1989, Frequent amplification of the bcl-1 locus in head and neck squamous cell carcinomas, Oncogene, 4, 1111 Yamamoto, 1986, High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines, Cancer Res, 46, 414 Wong, 1987, Expression of c-erbB proto-oncogene during dimethylbenzanthracene-induced tumorigenesis in hamster cheek pouch, Oncogene, 2, 67 Moroco, 1990, Sequential loss of suppressor genes for three specific functions during in vivo carcinogenesis, Lab Invest, 63, 298 Mercer, 1990, Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53, 87, 6166